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Objectives The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the
impact on in-hospital mortality.
Background Studies have evaluated predictors of delay in D2BT, highlighting system-related issues and patient demographic
characteristics. Limited data exist, however, for nonsystem reasons for delay in D2BT.
Methods We analyzed nonsystem reasons for delay in D2BT among 82,678 ST-segment elevation myocardial infarction
patients who underwent primary percutaneous coronary intervention within 24 h of symptom onset in the Cath-
PCI Registry from January 1, 2009, to June 30, 2011.
Results Nonsystem delays occurred in 14.7% of patients (n  12,146). Patients with nonsystem delays were more likely to
be older, female, African American, and have greater comorbidities. The in-hospital mortality for patients treated with-
out delay was 2.5% versus 15.1% for those with delay (p  0.01). Nonsystem delay reasons included delays in provid-
ing consent (4.4%), difficult vascular access (8.4%), difficulty crossing the lesion (18.8%), “other” (31%), and cardiac
arrest/intubation (37.4%). Cardiac arrest/intubation delays had the highest in-hospital mortality (29.9%) despite the
shortest time delay (median D2BT: 84 min; 25th to 75th percentile: 64 to 108 min); delays in providing consent had
a relatively lower in-hospital mortality rate (9.4%) despite the longest time delay (median D2BT: 100 min; 25th to
75th percentile: 80 to 131 min). Mortality for delays due to difficult vascular access, difficulty crossing a lesion, and
other was also higher (8.0%, 5.6%, and 5.9%, respectively) compared with nondelayed patients (p  0.0001). After
adjustment for baseline characteristics, in-hospital mortality remained higher for patients with nonsystem delays.
Conclusions Nonsystem reasons for delay in D2BT in ST-segment elevation myocardial infarction patients presenting for pri-
mary percutaneous coronary intervention are common and associated with high in-hospital mortality. (J Am
Coll Cardiol 2013;61:1688–95) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.073Rapid and successful reperfusion with primary percutaneous
coronary intervention (PCI) is the goal of initial treatment
in patients presenting with ST-segment elevation myocar-
dial infarction (STEMI). Supporting the belief that “time is
muscle,” previous studies have validated that incremental
delays in door-to-balloon time (D2BT) negatively affect
clinical outcomes, including both in-hospital (1) and long-
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April 23, 2013:1688–95 Nonsystem Delays in D2BT and Mortalityreal-world registry data reveal that a large proportion of patients
continue to fail undergoing PCI within this time frame (6,7).
Determining reasons for D2BT delay in primary PCI for
STEMI patients provides an opportunity to improve quality
of care for these patients. A number of studies have highlighted
certain systems issues and patient demographic characteristics
(8,9) as predictors of delay, including need for hospital
transfer, non-daytime presentation, low-volume centers, older
age, female sex, and nonwhite race (9). In response to these
system reasons for delays, a number of organizations have
implemented programs to meet the D2BT benchmark of
90 min and timely access to PCI (10,11), with improve-
ments in D2BT compliance (7).
Although system reasons for delay have garnered atten-
tion from a hospital administration and emergency services
standpoint, there are limited data on nonsystem reasons for
delays. Importantly, nonsystem reasons for delay may ac-
count for some of the disparities between guidelines and
clinical performance. Examples of nonsystem delays include
delays in providing procedure consent, difficult vascular
access, difficulty crossing the culprit lesion, and patients who
have a cardiac arrest requiring intubation before PCI. The
purpose of the present study was to evaluate the frequency
and associated mortality of nonsystem delays in D2BT in
STEMI patients presenting to hospitals with primary PCI
capabilities in the national CathPCI Registry.
We hypothesized that nonsystem delays would be fre-
quent and associated with higher mortality and adverse
clinical events based on 2 reasons. First, greater ischemic
time as a result of substantial delays in reperfusion would
portend a higher mortality (1–4,12). Second, reasons for
nonsystem delays are often related to pre-existing patient
comorbidities, a higher risk of myocardial infarction presen-
tation, and higher risk coronary anatomy that are surrogate
markers for advanced disease and poorer clinical outcomes.
Methods
Data collection. The CathPCI Registry is a large national
registry of patients undergoing diagnostic cardiac catheter-
izations and/or PCI, and details of the registry have been
previously described (13,14). The present study used version
4.3 of the CathPCI Registry, in which nonsystem reasons
for delays were first collected for analysis.
Study population. A retrospective analysis of CathPCI
Registry data was performed to assess nonsystem reasons for
delay in D2BT in STEMI patients and the associated
in-hospital mortality outcomes between January 1, 2009,
and June 30, 2011. We included patients who had electro-
cardiographic evidence of ST-segment elevations, presented
within 12 hours of symptom onset to emergency depart-
ments at acute care hospitals with primary PCI capabilities,
and subsequently underwent primary PCI with a D2BT
12 h. Excluded were patients 18 or 90 years of age,
STEMI transfers, thrombolysed patients, and low-volume
centers (average of 6 primary PCIs for STEMI annually).Statistical analysis. Nonsystem
reasons for delay in primary PCI
must be documented in the med-
ical chart to be abstracted into
the CathPCI Registry data col-
lection form, and specific non-
system reasons collected included
patient delays in providing con-
sent for the procedure, difficult
vascular access, difficulty crossing
the culprit lesion during the PCI,
and cardiac arrest and/or need
for intubation before PCI. Also
captured were unclassified non-
system reasons for delay labeled
as “other.” Baseline patient sub-
groups are presented as counts
with percentages for categorical
variables and the median with
interquartile range (IQR) for
continuous variables. An imputation method was used, such
that glomerular filtration rate was imputed to the gender-
specific and renal failure–specific medians. Likewise, ejec-
tion fraction was imputed to medians specific to congestive
heart failure (CHF), cardiogenic shock, and previous myo-
cardial infarction. Statistical comparison of between-group
differences was performed by using chi-square tests for
categorical variables and the Kruskal-Wallis test for contin-
uous variables. Statistical significance was defined as a
2-sided p  0.05 for all comparisons. All statistical analyses
were performed by the Duke Clinical Research Institute
using SAS version 9.3 (SAS Institute, Cary, North
Carolina).
Multivariable logistic regression modeling with general-
ized estimating equations was performed to evaluate if
nonsystem reasons for delay were independent predictors of
in-hospital mortality while adjusting for within-hospital
correlation by using the CathPCI Registry’s previously
validated model for mortality after PCI (15). The reference
group consisted of patients with no reported nonsystem
delay. Variables in the mortality model included: age, gender,
race, cardiogenic shock, previous CHF, valve surgery/
procedure, cardiovascular disease, peripheral vascular disease
(PVD), chronic lung disease, previous PCI, pre–intra-aortic
balloon pump (IABP), ejection fraction, glomerular filtration
rate, body mass index, dialysis, New York Heart Association
CHF class, highest risk segment category, highest risk lesion
pre–Thrombolysis In Myocardial Infarction (TIMI) flow,
highest risk Society for Cardiovascular Angiography and In-
terventions class, PCI status, and diabetes.
Results
Frequency of nonsystem delays and baseline and angiographic
characteristics. During the study period, 82,678 STEMI
Abbreviations
and Acronyms
CHF  congestive heart
failure
D2BT  door-to-balloon
time
IABP  intra-aortic balloon
pump
IQR  interquartile range
OR  odds ratio
PCI  percutaneous
coronary intervention
PVD  peripheral vascular
disease
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarctionpatients presented to 1,172 participating centers after ap-
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Registry database (Fig. 1). Median D2BT was 65 min
(IQR: 50 to 83 min), with 18.9% of patients having D2BT
90 min. Of these 82,678 patients, 14.7% (n  12,146)
were reported to have nonsystem reasons for delay. D2BTs
were longer (median: 92 min; IQR: 70 to 115 min) for
patients with nonsystem delays compared with patients
not reporting delays (median: 63 min; IQR: 48 to 78
min).
The nonsystem reasons for delay and frequency of each
occurrence were as follows: delays in providing procedure
consent (4.4% [n  535]), difficult vascular access (8.4%
[n  1,017]), difficulty crossing lesion (18.8% [n  2,289]),
other (31.0% [n  3,761]), and cardiac arrest/need for
ntubation (37.4% [n  4,544]). Table 1 summarizes the
frequency of each nonsystem delay and baseline characteristics.
Overall, patients with nonsystem delays were more likely
to be older, female, or African American, and have a history
of hypertension, diabetes, previous myocardial infarction,
previous CHF, previous coronary artery bypass graft, dial-
ysis, cerebrovascular disease, PVD, or chronic lung disease
compared with nondelayed patients. Patients with delayed
D2BT due to delays in providing consent were more likely
to be older, female, and nonwhite compared with other
nonsystem reasons for delay. Patients delayed due to difficult
vascular access were more likely to be smokers and have
PVD. Patients delayed due to difficulty in crossing the
culprit lesion were more likely to be male and to have a
history of dyslipidemia, previous PCI, and previous coro-
nary artery bypass graft. Delays in primary PCI due to
cardiac arrest/intubation included patients with less fre-
quent cardiovascular risk factors of hypertension, dyslipide-
Figure 1 Study Population
Flowchart of study patients. D2BT  door-to-balloon time; PCI  percutaneous cormia, and diabetes. cTable 2 summarizes angiographic and procedural char-
acteristics associated with nonsystem delays. Patients de-
layed due to difficult vascular access had a greater frequency
of radial and brachial entry sites relative to femoral access.
Delays due to difficulty in crossing the culprit lesion were
more frequent in left circumflex arteries and associated with
longer lesion length. In this group, the presence of throm-
bus and complete post-procedure TIMI flow grade 3 were
less frequent. Patients with cardiac arrest/intubation delays
more frequently had left main and left anterior descending
artery culprits, presence of thrombus, cardiogenic shock
before PCI, and placement of an IABP or other mechanical
ventricular support placed before PCI.
D2BT for nonsystem delays. Patients with nonsystem
delays did not necessarily all have a D2BT90 min (Table 3).
Patients with delays due to providing consent had a median
and a 25th to 75th percentile D2BT range of 100 min and 80
to 131 min, respectively. This represented the longest time
delay and resulted in 67% of patients missing the recom-
mended American College of Cardiology/American Heart
Association 90-min D2BT guideline (5). Patients with delays
due to cardiac arrest/need for intubation had a median and a
25th to 75th percentile D2BT range of 84 min and 64 to 108
min, respectively. This represented the shortest time delay.
Although the time to device deployment was “delayed” due to
each nonsystem reason, 47% of patients reported to have
nonsystem delays still met D2BT guidelines of 90 min.
ortality outcomes and adverse events. The overall,
n-hospital mortality for patients without reported nonsys-
em delays was 2.5% compared with 15.1% (p 0.0001) for
hose with a reported nonsystem delay (Fig. 2A). Mortality
ates for each nonsystem delay were as follows: difficulty
intervention; STEMI  ST-segment elevation myocardial infarction.onaryrossing lesion (5.6%), other (5.9%), difficult vascular access
nonsys
rt failur
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April 23, 2013:1688–95 Nonsystem Delays in D2BT and Mortality(8.0%), delay in providing consent (9.4%), and cardiac arrest/
intubation (29.9%) (Fig. 2B). All mortality rates associated
with each nonsystem reason for delay were significantly higher
compared with nondelayed patients (p  0.0001).
After adjustment for baseline characteristics in a multi-
variable regression model, risks of in-hospital mortality were
calculated for cardiac arrest/intubation versus no delay and
for all other combined nonsystem delays versus no delay
(Table 4). In this model, the adjusted odds of mortality
remained significantly higher for patients with a cardiac
arrest/intubation delay compared with those with no delay
(odds ratio [OR]: 3.4 [95% confidence interval: 3.1 to 3.8])
and for all other combined nonsystem delays versus no delay
(OR: 1.7 [95% confidence interval: 1.5 to 1.9]). Adjusted
in-hospital mortality was also analyzed after stratifying
patients according to D2BT (90 min or 90 min). The
mortality OR was similar for all other combined nonsystem
delays regardless of D2BT (Table 4).
Post-procedure adverse events (cardiogenic shock, CHF,
cerebrovascular accident/stroke, renal failure, any vascular
complications, and bleeding events within 72 h) were also
more common in patients delayed for nonsystem reasons
compared with nondelayed patients (Table 5).
Discussion
To the best of our knowledge, this is the first report of the
frequency, magnitude, and associated mortality for nonsys-
tem reasons for a delay in PCI for STEMI patients
Baseline Characteristics and Frequency of Patients With and WithoTable 1 Baseline Characteristics and Frequency of Patients W
Patient Characteristic
No Report of
Nonsystem Delay
Nonsystem
Delay p Value
Patients 70,532 (85.3) 12,146 (14.7)
Age (yrs) 60.3 12.4 62.9 13.1 0.001
Male 52,022 (73.8) 8,338 (68.6) 0.001
Race/ethnicity
White 62,036 (88.0) 10,520 (86.6) 0.001
Black 5,619 (8.0) 1,123 (9.3) 0.001
Asian 1,914 (2.7) 337 (2.8) 0.703
Hispanic 4,231 (6.0) 783 (6.5) 0.055
Body mass Index (kg/m2) 29.1 6.0 29.0 6.5 0.0001
Smoker 30,686 (43.5) 4,900 (40.3) 0.0001
Hypertension 45,304 (64.2) 8,332 (68.6) 0.0001
Dyslipidemia 44,199 (62.7) 7,427 (61.2) 0.001
Diabetes 15,605 (22.1) 3,185 (26.2) 0.0001
Family history of CAD 15,343 (21.8) 2,182 (18.0) 0.0001
Previous MI 13,348 (18.9) 2,619 (21.6) 0.0001
Previous CHF 2,604 (3.7) 894 (7.4) 0.0001
Previous PCI 15,165 (21.5) 2,656 (21.9) 0.363
Previous CABG 3,743 (5.3) 1,099 (9.1) 0.0001
Dialysis 523 (0.7) 221 (1.8) 0.0001
Cerebrovascular disease 4,320 (6.1) 1,148 (9.5) 0.0001
Peripheral vascular disease 3,608 (5.1) 1,162 (9.6) 0.0001
Chronic lung disease 6,237 (8.8) 1,526 (12.6) 0.0001
Values are n (%) or mean  SD. Frequency of all combined nonsystem delays and each separate
CABG  coronary artery bypass graft; CAD  coronary artery disease; CHF  congestive heapresenting to centers with primary PCI capabilities. Ourhypothesis that nonsystem delays would be frequent and
associated with higher mortality and adverse events was
supported by this analysis and was related to patient
comorbidities and higher risk presentation rather than
greater ischemic time from a substantial delay in reperfu-
sion. This is in contrast to other analyses on system delays
and D2BT, which report an increase in associated mortal-
ities with incremental time delays in D2BT (1–4,8).
Cardiac arrest/intubation delays. We found that the most
frequent nonsystem delay was in patients presenting with a
cardiac arrest requiring intubation before PCI (37.4%). As
expected, this group had the highest in-hospital mortality
rate (30%). This figure is similar to that of a large prospec-
tive, single-center observational study which found that
STEMI cardiac arrest patients requiring transfer to a PCI
hospital had a mortality rate of 30.6% at the index hospital
and 44.2% at the PCI center (16). Internationally, investi-
gators have found that resuscitated cardiac arrest STEMI
patients requiring intubation is an independent predictor of
both in-hospital and long-term mortality (17). Interest-
ingly, baseline characteristics of patients in this group did
not include an increased relative frequency of smokers,
chronic lung disease, or previous CHF compared with other
nonsystem reasons for delay. Instead, these patients were
more likely to have anterior wall injury (left main or left
anterior descending lesions) and cardiogenic shock requiring
IABP or other mechanical support, indicating that left
ventricle pump failure and acute CHF were the main
onsystem Delaysd Without Nonsystem Delays
lays in
nsent
Difficult
Access
Difficulty
Crossing Lesion
Cardiac Arrest/
Intubation Other
(4.4) 1,017 (8.4) 2,289 (18.8) 4,544 (37.4) 3,761 (31.0)
 14.9 63.6 12.8 64.2 12.9 61.9 12.7 62.5 13.2
(57.9) 653 (64.2) 1,666 (72.8) 3,155 (69.4) 2,554 (67.9)
(82.8) 903 (88.8) 2,010 (87.8) 3,908 (86.0) 3,256 (86.6)
(10.1) 83 (8.2) 197 (8.6) 439 (9.7) 350 (9.3)
(6.0) 21 (2.1) 58 (2.5) 130 (2.9) 96 (2.6)
(6.0) 60 (5.9) 144 (6.3) 286 (6.3) 261 (6.9)
 6.5 29.9 8.0 29.2 6.1 29.0 6.6 28.9 6.2
(33.3) 488 (48.0) 818 (35.7) 1,947 (42.9) 1,469 (39.1)
(72.9) 751 (73.8) 1,678 (73.3) 2,908 (64.0) 2,605 (69.3)
(60.6) 658 (64.7) 1,545 (67.5) 2,543 (56.0) 2,357 (62.7)
(29.7) 293 (28.8) 600 (26.2) 1,159 (25.5) 974 (25.9)
(13.8) 210 (20.7) 447 (19.5) 688 (15.1) 763 (20.3)
(20.0) 254 (25.0) 595 (26.0) 848 (18.7) 815 (21.7)
(9.4) 67 (6.6) 182 (8.0) 371 (8.2) 224 (6.0)
(17.2) 260 (25.6) 622 (27.2) 880 (19.4) 802 (21.3)
(8.0) 107 (10.5) 308 (13.5) 292 (6.4) 349 (9.3)
(2.6) 18 (1.8) 38 (1.7) 89 (2.0) 62 (1.7)
(13.8) 99 (9.7) 222 (9.7) 418 (9.2) 335 (8.9)
(9.9) 277 (27.2) 184 (8.0) 368 (8.1) 280 (7.4)
(14.6) 146 (14.4) 271 (11.8) 600 (13.2) 431 (11.5)
tem reason for delay in door-to-balloon time and associated baseline characteristics.
e; MI  myocardial infarction; PCI  percutaneous coronary intervention.ut Nith an
De
Co
535
67.9
310
443
54
32
32
27.6
178
390
324
159
74
107
50
92
43
14
74
53
78reasons for intubation. The median D2BT of 84 min
ite was
; TIMI 
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treated expeditiously within the 90-min D2BT, suggesting
that the intubation process occurred quickly.
Delays due to difficulty in obtaining vascular access and
crossing the culprit lesion. The next most frequent non-
system reasons for delay were due to difficult vascular access
(8.4%) and difficulty crossing the culprit lesion (18.8%).
Together, these accounted for 3,306 patients over the study
period. Interestingly, although the delay for each reason
resulted in a similar median and 25th to 75th percentile
range for D2BT, the associated mortality between the 2 was
significantly different (8.0% vs. 5.6%, respectively; p 
0.02). This finding suggests that the higher mortality
associated with patients who have difficult vascular access
may be independent of D2BT. The patients delayed for
difficulty with vascular access had a higher prevalence of
Angiographic and Procedural Characteristics of Patients With andTable 2 Angiographic and Procedural Characteristics of Patien
Angiographic/Procedural
Characteristic
No Report of
Nonsystem Delay
(n  70,532)
Nonsystem
Delay
(n  12,146) p Value
Culprit lesion
Left main 291 (0.4) 277 (1.9) 0.0001
LAD 26,932 (38.2) 4,864 (40.1) 0.0001
Circumflex 10,105 (14.3) 1,989 (16.4) 0.0001
RCA 32,877 (46.6) 4,998 (41.2) 0.0001
Lesion length (mm) 20.9 10.9 21.0 11.9 0.0018
Bifurcation 7,792 (11.1) 1,482 (12.2) 0.0002
Thrombus present 39,178 (55.6) 6,592 (54.3) 0.0098
Post-procedure 67,406 (95.6) 10,588 (87.2) 0.0001
TIMI flow (complete)
Percutaneous entry site*
Femoral 68,567 (97.2) 11,709 (96.4) 0.0001
Brachial 76 (0.1) 100 (0.8) 0.0001
Radial 1,857 (2.6) 328 (2.7) 0.0001
Contrast volume (cc) 198.1 80.5 219.4 99.2 0.0001
Fluoroscopy time (min) 12.4 9.0 17.4 13.1 0.0001
IABP (any) 5,428 (7.7) 2,795 (23.0) 0.0001
At start of procedure 102 (1.9) 128 (4.6) —
During procedure, before PCI 1,066 (19.6) 1,033 (37.0) —
After PCI 4,257 (78.4) 1,634 (58.5) —
Other mechanical ventricular
support
431 (0.6) 408 (3.4) 0.0001
Cardiogenic shock at start of PCI 3,974 (5.6) 3,176 (26.2) 0.0001
Values are n (%) or mean SD. Angiographic and procedural characteristics associated with all com
location of percutaneous entry; site used to perform a majority of the procedure if more than 1 s
IABP  intra-aortic balloon pump; LAD  left anterior descending; RCA  right coronary artery
Door-to-Balloon Times of Patients With and Without Nonsystem DeTable 3 Door-to-Balloon Times of Patients With and Without No
D2BT Variable (min)
No Report of
Nonsystem Delay
(n  70,532)
Nonsystem
Delay
(n  12,146)
Delay
Cons
(n  5
Median 63.0 92.0 100
25th percentile 48.0 70.0 80
75th percentile 78.0 115.0 131
90 min 13% 53% 67Median, 25th to 75th percentile range, and overall percentage of patients in each delay category that
door-to-balloon time (D2BT) as a result of nonsystem delays. p  0.0001 for differences in the distributiPVD (27.2%), which may explain the higher mortality
seen in this group because patients with PVD are more
likely to have a greater degree of systemic and coronary
atherosclerosis. Previous data support that PVD in pa-
tients with acute coronary syndromes undergoing PCI is
an independent predictor of in-hospital death (18 –22).
In 1 study, the adjusted mortality OR of PVD patients
presenting with STEMI was 2.6 (95% confidence inter-
val: 1.23 to 5.65) compared with patients without PVD
(23). In our study, we found a higher frequency of use of
nonfemoral access sites in the delay due to difficult
vascular access group. This finding may be due to a failed
femoral attempt, with conversion to either a radial or
brachial approach.
We found that the timing of IABP placement, when
operators had difficulty crossing the culprit lesion, was more
ut Nonsystem Delayth and Without Nonsystem Delay
lays in
onsent
 535)
Difficult
Access
(n  1,017)
Difficulty
Crossing Lesion
(n  2,289)
Cardiac Arrest/
Intubation
(n  4,544)
Other
(n  3,761)
4 (0.8) 4 (0.4) 13 (0.6) 156 (3.4) 50 (1.3)
8 (42.6) 366 (36.0) 798 (34.9) 2,018 (44.4) 1,454 (38.7)
0 (16.8) 159 (15.6) 399 (17.4) 713 (15.7) 628 (16.7)
9 (39.1) 481 (47.3) 1,065 (46.5) 1,634 (36.0) 1,609 (42.8)
.6 12.1 21.0 11.5 20.7 12.8 21.3 11.8 20.8 11.6
0 (11.2) 108 (10.6) 280 (12.2) 591 (13.0) 443 (11.8)
8 (53.8) 570 (56.1) 1,103 (48.2) 2,599 (57.2) 2,032 (54.0)
1 (91.8) 927 (91.1) 1,745 (76.2) 3,935 (86.6) 3,490 (92.8)
9 (97.0) 859 (84.5) 2,227 (97.3) 4,459 (98.1) 3,645 (96.9)
2 (0.4) 76 (7.5) 3 (0.1) 14 (0.3) 5 (0.1)
4 (2.6) 80 (7.9) 56 (2.5) 69 (1.5) 109 (2.9)
.4 87.8 237.5 107.9 257.2 112.1 205.0 92.4 211.4 90.8
.8 9.9 20.2 13.5 25.7 16.7 15.3 11.2 14.7 10.6
7 (8.8) 89 (8.8) 304 (13.3) 1,842 (40.5) 513 (13.6)
3 (6.4) 1 (1.1) 5 (1.6) 100 (5.4) 19 (3.7)
2 (25.5) 24 (27.0) 64 (21.1) 717 (38.9) 216 (42.1)
2 (68.1) 64 (71.9) 235 (77.3) 1,025 (55.7) 278 (54.2)
2 (0.4) 15 (1.5) 24 (1.1) 318 (7.0) 49 (1.3)
0 (9.4) 101 (9.9) 164 (7.2) 2,396 (52.7) 465 (12.4)
nonsystem delays and each separate nonsystem reason for delay in door-to-balloon time. *Primary
used.
Thrombolysis In Myocardial Infarction; other abbreviation as in Table 1.
tem Delay
Difficult
Access
(n  1,017)
Difficulty
Crossing Lesion
(n  2,289)
Cardiac Arrest/
Intubation
(n  4,544)
Other
(n  3,761)
92.0 92.0 84.0 99.0
74.0 72.0 64.0 76.0
110.0 109.0 108.0 130.0
54% 53% 43% 62%Withots Wi
De
C
(n
22
9
20
20
6
28
49
51
1
201
14
4
1
3
5
binedlaynsys
s in
ent
35)
.0
.0
.0
%missed the American College of Cardiology/American Heart Association–recommended 90-min
on of D2BT for each nonsystem reason for delay compared with no delay.
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April 23, 2013:1688–95 Nonsystem Delays in D2BT and Mortalitylikely to be after PCI, as opposed to patients with cardiac
arrest/intubation who had a relatively higher frequency of
IABPs implanted before the start of the PCI. Patients with
difficult-to-cross culprit lesions were less likely to have
TIMI flow grade 3 post-procedure, which may explain the
IABP placement at that time. The timing of IABP place-
ment likely had no significant impact on overall D2BT
Figure 2 In-Hospital Mortality of Patients With and Without No
(A) In-hospital mortality for patients with no report of nonsystem delay compared w
each separate nonsystem reason for delay.
Risk-Adjusted In-Hospital MortalityTable 4 Risk-Adjusted In-Hospital Mortality
D2BT Category
U
Mortality
OR
Lowe
(95%
All times Cardiac arrest delay (vs. no delay) 16.8 15.5
All other delays (vs. no delay) 2.7 2.4
If D2BT 90 min Cardiac arrest delay (vs. no delay) 14.2 12.9
All other delays (vs. no delay) 2.7 2.3
If D2BT 90 min Cardiac arrest delay (vs. no delay) 17.9 15.2
All other delays (vs. no delay) 2.2 1.9
In-hospital mortality odds ratio (OR) in a multivariable analysis stratified according to door-to-balloo
valve surgery/procedure, cardiovascular disease, peripheral vascular disease, chronic lung disease
Heart class, highest risk segment category, highest risk lesion pre–Thrombolysis In Myocardial Inf
diabetes.
CI  confidence interval; OR  odds ratio; other abbreviations as in Tables 1 and 2.given the pre-PCI placement in the cardiac arrest/
intubation group, which had the shortest median D2BT
among nonsystem delay groups. Furthermore, our multi-
variable regression model adjusted for pre-operative IABP
(in place at the start of the procedure), and a significantly
higher mortality OR was found for all nonsystem delay
groups regardless of overall D2BT.
em Delay
tients with a nonsystem reason for delay. (B) Associated in-hospital mortality for
sted Adjusted
Upper
(95% CI) p Value
Mortality
OR
Lower
(95% CI)
Upper
(95% CI) p Value
18.3 0.001 3.4 3.1 3.8 0.001
3.0 0.001 1.7 1.5 1.9 0.001
15.7 0.001 3.0 2.6 3.5 0.001
3.1 0.001 1.7 1.5 2.1 0.001
21.1 0.001 3.8 3.1 4.8 0.001
2.7 0.001 1.6 1.3 1.9 0.001
D2BT) after adjustment for age, gender, race, cardiogenic shock, previous congestive heart failure,
us PCI, pre-IABP, ejection fraction, glomerular filtration rate, body mass index, dialysis, New York
flow, highest risk Society for Cardiovascular Angiography and Interventions class, PCI status, andnsyst
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r
CI)
n time (
, previo
arction
r
m
S
D
c
p
w
s
t
a
c
f
m
d
e
t
p
o
S
r
d
c
i
t
a
e
s
g
n
b
e
c
s
4
w
w
u
d
C
N
a
n
b
r
q
p
d
p
g
rate no
1694 Swaminathan et al. JACC Vol. 61, No. 16, 2013
Nonsystem Delays in D2BT and Mortality April 23, 2013:1688–95Delays in providing consent. This nonsystem reason re-
sulted in the longest delays among those evaluated, and
two-thirds of these patients missed the recommended 90-
min D2BT. The in-hospital mortality rate for this group
was 9.4%. Unlike the aforementioned nonsystem delays that
are generally surrogates for advanced disease and cannot be
modified, the consenting process may provide an opportu-
nity for substantial improvement and reduction in delays.
For example, healthcare providers initially treating and
triaging patients should be permitted to begin conversations
regarding the procedure with the patient and family so as to
expedite obtaining the informed consent by a member of the
PCI team. Given more lead time to think about these issues
while en route to the primary PCI center may help expedite
the consenting process on arrival. Interestingly, our study
also showed that Asian patients with nonsystem delays were
more likely to be delayed for not providing timely consent.
Perhaps a cultural bias or language barrier led to the delay in
obtaining informed consent in a subgroup of these patients.
This possibility raises the notion that a system solution to
making interpreters rapidly available may help reduce the
delays in obtaining consents for emergent PCI.
Mortality outcomes and D2BT. Nonsystem reasons for
delay were associated with higher mortality outcomes even
after adjustment for baseline characteristics. Interestingly, we
noted that a similar mortality risk existed in nonsystem delay
groups regardless of whether the D2BT was 90 min. This
aises the question: Would further improvements in D2BT
easures actually improve mortality? A recent analysis of
TEMI patients in Michigan showed significant reductions in
2BT over 5 years, yet in-hospital mortality remained un-
hanged at approximately 4% (24). Differences in clinical risk
resentation and symptom onset-to-door time may explain
hy mortality does not always correlate with D2BT. In our
tudy, patients with a cardiac arrest requiring intubation fell in
he highest risk category and had the highest mortality despite
shorter D2BT. Patients with nonsystem delays related to
onsent might also have delayed their presentation to hospitals
rom the time of symptom onset due to hesitancy in seeking
edical attention and treatment. The benefit of reperfusion
ecreases with time such that there may be no mortality benefit
ven if treated within 90 min if the symptom onset-to-door
In-Hospital Adverse Outcomes of Patients With and Without NonsyTable 5 In-Hospital Adverse Outcomes of Patients With and Wi
Adverse Outcomes
No Report of
Nonsystem Delay
(n  70,532)
Nonsystem
Delay
(n  12,146) p Value
Cardiogenic shock 1,990 (2.8) 840 (7.3) 0.0001
CHF 1,755 (2.5) 676 (5.9) 0.0001
CVA/stroke 263 (0.4) 120 (1.0) 0.0001
Renal failure 225 (0.3) 160 (1.4) 0.0001
Any vascular complications 384 (0.6) 128 (1.1) 0.0001
Bleeding event within 72 h 2,375 (3.4) 796 (6.9) 0.0001
Values are n (%). In-hospital adverse outcomes for all combined nonsystem delays and each sepa
CHF  congestive heart failure; CVA  cerebrovascular accident.ime is already substantial. This highlights the importance ofublic education for seeking rapid medical attention at the
nset of typical chest pain symptoms.
tudy limitations. The CathPCI Registry is an ideal,
eal-world registry used to study the frequency of nonsystem
elays and associated mortality. The registry includes data
ollected from approximately 60% of the cardiac catheter-
zation laboratories in the United States (25). Nevertheless,
here are limitations to the database. CathPCI Registry data
re retrospective and observational. Because the registry
ncapsulates all-comers, there is the possibility of unmea-
ured confounding. The data are abstracted from a hetero-
eneous mixture of facilities that vary in the types and
umbers of procedures performed. We tried to limit this
ias by excluding low-volume centers. Individual operator
xperience may have affected the ability to obtain access or
ross a difficult lesion, which was not controlled for in this
tudy. Version 4.3 of the CathPCI Registry form classified
nonsystem reasons for delay in D2BT. The other group
as unclassified and accounted for 31% of patients who
ere delayed for nonsystem reasons. We were limited in our
nderstanding of this unclassified group, because the form
id not require specific descriptions for the “other” reason.
onclusions
onsystem reasons for delay in D2BT are common and
ssociated with high in-hospital mortality. The frequency of
onsystem reasons for delay may account for disparities seen
etween guidelines and clinical practice. Some nonsystem
easons for delay may have system solutions to improve
uality of care, such as adjustments to the consenting
rocess. These system solutions to nonsystem reasons for
elay should be scrutinized to discern any potential im-
rovements in the quality of care delivered to this high-risk
roup of patients.
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